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Since its introduction into clinical practice a few de-
cades ago, noninvasive positive pressure ventilation 
(NIV) has shown a triumphal advance with applications 
in a broad range of settings including anesthesia and peri-
operative care, critical care, respiratory and sleep medi-
cine. Major reasons for this success are patient related, 
i.e., improved outcomes in terms of mortality, morbidity, 
need of hospitalization and, hence, quality of life. This is 
due to the avoidance of invasive airway instrumentation, 
no need for sedation and muscular relaxation, and the op-
portunity to apply NIV intermittently allowing for com-
munication, oral fluid and food intake during breaks, or 
application of NIV predominantly during nocturnal 
sleep, which facilitates social integration of many patients 
with chronic hypercapnic respiratory failure. Constantly 
evolving technical advances such as the development of 
novel, powerful turbines for pressure and flow generation 
by light-weight, portable devices, sophisticated software 
supporting control of NIV as well as convenient and com-
fortable patient interfaces are also essential for the ongo-
ing progress of NIV. A large number of innovative studies 
have helped to better understand the mechanisms of ac-
tion of NIV in different settings and the key factors re-
sponsible for its clinical success. Although, in some areas, 
early applications of NIV by enthusiastic clinicians have 
run ahead of an evidence-based corroboration of its effi-
cacy, ongoing research is continuously filling many of 
these gaps.
In view of the many advances in one particular field of 
NIV, i.e., its use in patients with chronic hypercapnic re-
spiratory failure, which is important for respiratory, crit-
ical care, and sleep physicians alike, we have launched the 
current Thematic Review Series. The purpose is to pro-
vide the readers of Respiration a current update on se-
lected topics with new developments and trends in this 
rapidly evolving field. Thus, one article will highlight the 
pathophysiology of chronic respiratory failure which may 
be caused by a combination of altered mechanics and gas 
exchange in lung and chest wall disease, respiratory mus-
cle weakness of various etiologies, and alterations in neu-
ral control of breathing. Chronic respiratory failure may 
also be associated with instability of control of breathing 
leading to a periodic breathing pattern with frequent cen-










































































an individual patient-tailored approach using specific 
NIV modes that are discussed in the Thematic Review 
Series. Recent trials have generated new evidence on the 
use of NIV in patients with chronic obstructive lung dis-
ease associated with chronic hypercapnic respiratory fail-
ure. These results will be critically reviewed to guide suc-
cessful application of NIV in an area that has long been 
controversial. A further particular focus is put on a rela-
tively new application of NIV, the ventilatory support 
during rehabilitation, which should allow patients to bet-
ter regain mobility and independence in everyday life. Al-
though the main purpose of NIV, supporting inspiratory 
muscles to enhance alveolar ventilation, is technically fea-
sible in the majority of conditions, the sustained, success-
ful application is often compromised by practical hin-
drances related to the patient-ventilator interface, moni-
toring of efficacy and side effects, and other practical 
aspects addressed in a particular contribution.
With major advances in medicine, the number of old-
er patients with more severe and longer-term conditions 
requiring NIV and other therapeutic support prolonging 
survival is rapidly growing. Questions arise, which pa-
tients may really benefit not only in terms of immediate 
physiological success but in terms of improvement in 
symptoms and quality of life in the long term. Ethical 
considerations gain increasing importance when making 
treatment recommendations to patients with advanced, 
chronic conditions and these also need a critical discus-
sion.
We are convinced that the different contributions to 
this Thematic Review Series on NIV by an international 
group of authors will provide scientifically sound and 
clinically useful insights to the readers that may assist in 
the selection and practical application of this valuable and 
highly effective treatment modality for patients with var-
ious forms of chronic hypercapnic ventilatory failure.
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